trial
as of 2026-07-01Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
NCTId NCT02013609
at a glance
Phase 3 · Completed
Enrollment 48 (actual)
Primary completion 2014-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 3
Status
Completed
Enrollment
48 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2013-11
Primary completion
2014-09
Eligibility
ALL · 18 Years · 35 Years
Interventions & indications
Sponsors
Investigators
1
Jun-ichi Hashimoto, PhDStudy Director
Sites
0 total
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
48
Phase
PHASE3
Primary Completion Date
2014-09
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
collaborator
indication
investigator
person